A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.
Clinical trial NCT00773383 · TERMINATED
Trial details
- NCT number
- NCT00773383
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-02-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.